Biodentine Versus White MTA Pulpotomy

The Clinical and Radiographic Efficacy of Biodentine™ and White Mineral Trioxide Aggregate in Deciduous Molar Pulpotomy - a Randomized Control Trial

A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth.

Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.

Inclusion Criteria:

• Patients (Children with carious deciduous molars indicated for pulpotomy) belonging to the category of ASA I according to the 'American Society of Anaesthesiologists'.
• Patients without any known medical history of systemic complications contradicting pulp treatment.
• Patients are indicated for treatment under general anaesthesia due to polycaries / fear / anxiety / very young age.
• Written consent is obtained from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes.